February 2024 Price Concessions 1st Update

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (13/02/2024) announced the following initial list of price concessions for February 2024.

Drug Pack size Price concession
Atorvastatin 80mg tablets 28 £2.64
Azithromycin 250mg capsules 6 £4.67
Bimatoprost 300micrograms/ml / Timolol 5mg/ml eye drops 3 £4.55
Bumetanide 1mg tablets 28 £2.69
Clarithromycin 500mg tablets 14 £7.63
Co-amoxiclav 500mg/125mg tablets 21 £4.25
Co-codamol 30mg/500mg tablets 30 £1.32
Co-codamol 30mg/500mg tablets 100 £4.40
Cyclizine 50mg/1ml solution for injection ampoules 5 £5.56
Donepezil 5mg tablets 28 £1.85
Duloxetine 60mg gastro-resistant capsules 28 £3.65
Glycopyrronium bromide 200micrograms/1ml solution for injection ampoules 10 £11.80
Haloperidol 1.5mg tablets 28 £3.68
Hydrocortisone 2.5% cream 15 £46.83
Irbesartan 300mg tablets 28 £1.42
Isotretinoin 20mg capsules 30 £11.03
Ivabradine 7.5mg tablets 56 £4.51
Lamotrigine 100mg tablets 56 £3.51
Lamotrigine 200mg tablets 56 £5.15
Lamotrigine 25mg tablets 56 £1.92
Lamotrigine 5mg dispersible tablets sugar free 28 £10.05
Mebeverine 200mg modified-release capsules 60 £6.59
Memantine 10mg/ml oral solution sugar free 50 £45.46
Memantine 20mg tablets 28 £1.61
Metformin 1g modified-release tablets 56 £2.88
Metformin 500mg modified-release tablets 56 £1.83
Metformin 500mg/5ml oral solution sugar free 150 £26.50
Methylphenidate 10mg tablets 30 £3.09
Metoprolol 50mg tablets 28 £3.75
Montelukast 10mg tablets 28 £2.20
Montelukast 5mg chewable tablets sugar free 28 £1.21
Piroxicam 0.5% gel 60 £1.83
Piroxicam 0.5% gel 112 £3.43
Quinine sulfate 300mg tablets 28 £3.94
Risperidone 1mg/ml oral solution sugar free 100 £3.13
Simvastatin 80mg tablets 28 £1.61
Spironolactone 50mg tablets 28 £4.03

Please note: We are still in discussion with DHSC on a number other medicines affected by pricing issues this month. We will issue further updates as soon as we hear back from the Department.

No additional endorsements are required for price concessions. A price concession only applies for the month it is granted; any prices agreed for concessions requested late in the month will roll over into the following month.

We encourage pharmacies to report any problems obtaining a Part VIII product at or below the stated Drug Tariff price, using the online feedback form on the Community Pharmacy England website. Please include full details of the supplier and price paid for any products sourced above the Drug Tariff price. We will investigate the extent of the problem and, if appropriate, discuss the issue with DHSC.

Please  subscribe to our mailing list to receive email updates of any price concessions.

Further information on price  concessions and FAQs about the process  involved  can be found on our website (cpe.org.uk/priceconcessions) To hear more on how the current price  concessions system operates, pharmacy teams can now access a recording of our recent Medicines Supply and Concessions Briefing webinar  here.

Improvements to the price concession system

Following significant concerns raised by pharmacies about the unsustainable level of prices imposed by  DHSC  in second half of 2022, it was agreed that an  urgent review of the price concession setting system would take place.

Since this announcement, we have sent a strong and clear message back to Government that pharmacies cannot continue to subsidise the NHS medicines bill. Following the review of the concessionary price process, a package of measures has been developed to improve the system.

One of the solutions agreed between us and DHSC is that from 1st April 2023, all products granted a concessionary price will be classified as ‘Discount Not Deducted’ for the month(s) in which they are on concession.

Furthermore, from May 2023, DHSC has implemented a process to roll over prices to the following month for any concessions requested after the 23rd of the month provided these prices were agreed with us. We are also continuing to work with DHSC on how a ‘retrospective increased payment’ may apply, where appropriate. Further information regarding this concession ‘top-up’ mechanism will be issued once details are finalised.